In contrast, the myocyte-specific deletion of CerS5 and CerS6 did not affect insulin sensitivity and glucose metabolism in obesity, highlighting the tissue-specific regulation and roles of distinct CerSs and their specific ceramide products [28]. The gene discussed is INS; the disease is Obesity.